期刊文献+

Ets1 as a marker of malignant potential in gastric carcinoma 被引量:8

Ets1 as a marker of malignant potential in gastric carcinoma
下载PDF
导出
摘要 AIM: Ets1 proto-oncogene is a transcription factor involved in the activation of several genes of tumor invasion and metastasis. We aimed to determine the relationship between the extent and intensity of Ets1 expression and patients'' clinicopathological factors in gastric carcinoma. METHODS: Immunohistochemical analysis was performed for gastric tumor paraffin-embedded sections, followed by image analysis. RESULTS: Ets1 was not expressed in the normal gastric epithelium and its surrounding cells. The percentage of Ets1 expressing cells detected increased significantly in both epithelial tumor and stromal cells from high T classification, lymph node metastasis positive, clinical advanced-stage groups (P<0.05). The level of Etsl staining in epithelial tumor cells also reflected the degree of cell differentiation. The percentage of epithelial and stromal cells expressing Ets1 was significantly correlated with the presence of lymph node metastasis (P=0.014 and P=0.O01 respectively). Ets1 expression was not observed in tissue samples from patients with benign gastric ulcers.CONCLUSION: Ets1 protein expression in epithelial tumor cells reflects the degree of differentiation, and the percentage of Etsl positive tumor and stromal cells correlates with lymph node metastasis. Thus Etsl is a valuable marker of malignant potential in terms of invasiveness and metastasis of gastric carcinoma. It is also possible that inhibition of Etsl is a potential avenue for therapy in gastric cancer. AIM:Ets1 proto-oncogene is a transcription factor involved in the activation of several genes of tumor invasion and metastasis.We aimed to determine the relationship between the extent and intensity of Ets1 expression and patients' clinicopathological factors in gastric carcinoma. METHODS:Immunohistochemical analysis was performed for gastric tumor paraffin-embedded sections,followed by image analysis. RESULTS:Ets1 was not expressed in the normal gastric epithelium and its surrounding cells.The percentage of Ets1 expressing cells detected increased significantly in both epithelial tumor and stromal cells from high T classification, lymph node metastasis positive,clinical advanced-stage groups(P<0.05).The level of Ets1 staining in epithelial tumor cells also reflected the degree of cell differentiation.The percentage of epithelial and stromal cells expressing Ets1 was significantly correlated with the presence of lymph node metastasis(P=0.014 and P=0.001 respectively).Ets1 expression was not observed in tissue samples from patients with benign gastric ulcers. CONCLUSION:Ets1 protein expression in epithelial tumor cells reflects the degree of differentiation,and the percentage of Ets1 positive tumor and stromal cells correlates with lymph node metastasis.Thus Ets1 is a valuable marker of malignant potential in terms of invasiveness and metastasis of gastric carcinoma.It is also possible that inhibition of Ets1 is a potential avenue for therapy in gastric cancer.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2003年第10期2154-2159,共6页 世界胃肠病学杂志(英文版)
  • 相关文献

参考文献31

  • 1Hasegawa S, Furukawa Y, Li M, Satoh S, Kato T, Watanabe T,Katagiri T, Tsunoda T, Yamaoka Y, Nakamura Y. Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes.Cancer Res 2002; 62:7012-7017.
  • 2Yordy JS, Muise-Helmericks RC. Signal transduction and the Ets family of transcription factors. Oncogene 2000; 19:6503-6513.
  • 3Xu D, Wilson TJ, Chan D, De Luca E, Zhou J, Hertzog PJ, Kola I.Etsl is required for p53 transcriptional activity in UV-induced apoptosis in embryonic stem cells. EMBO J 2002; 21:4081-4093.
  • 4Wolvetang EJ, Wilson TJ, Sanij E, Busciglio J, Hatzistavrou T,Seth A, Hertzog PJ, Kola I. ETS2 overexpression in transgenic models and in Down syndrome predisposes to apoptosis via the p53 pathway. Hum Mol Genet 2003; 12:247-255.
  • 5Li X, Lu JY, Zhao LQ, Wang XQ, Liu GL, Liu Z, Zhou CN, Wu M,Liu ZH. Overexpression of ETS2 in human esophageal squamous cell carcinoma. World J Gastroenterol 2003; 9:205-208.
  • 6Zhou J, Ng AY, Tymms MJ, Jermiin LS, Seth AK, Thomas RS,Kola I. A novel transcription factor, ELF5, belongs to the ELF subfamily of ETS genes and maps to human chromosome 11p13-15, a region subject to LOH and rearrangement in human carcinoma cell lines. Oncogebe 1998; 17:2719-2732.
  • 7Baillat D, Begue A, Stehelin D, Aumercier M. ETS-1 transcription factor binds cooperatively to the palindromic head to head ETS-binding sites of the stromelysin-1 promoter by counteracting autoinhibition. J Biol Chem 2002; 277:29386-29398.
  • 8Rutter JL, Mitchell TI, Buttice G, Meyers J, Gusella JF, Ozelius LJ,Brinckerhoff CE. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 1998; 58:5321-5325.
  • 9Nakada M, Yamashita J, Okada Y, Sato H. Ets-1 positively regulates expression of urokinase-type plasminogen activator (uPA)and invasiveness of astrocytic tumors. J Neuropathol Exp Neurol 1999; 58:329-334.
  • 10Trojanowska M. Ets factors and regulation of the extracellular matrix. Oncogene 2000; 19:6464-6471.

同被引文献15

引证文献8

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部